Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


14.05.2018

1 Am J Surg Pathol
2 Blood
2 BMC Cancer
1 Bone Marrow Transplant
3 Br J Haematol
1 Cancer
3 Cancer Res
1 Eur J Haematol
3 Haematologica
1 Int J Cancer
1 J Virol
1 Lancet Oncol
1 Leuk Lymphoma
1 Leukemia
1 N Engl J Med
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. CARRERAS J, Yukie Kikuti Y, Miyaoka M, Hiraiwa S, et al
    Genomic Profile and Pathologic Features of Diffuse Large B-Cell Lymphoma Subtype of Methotrexate-associated Lymphoproliferative Disorder in Rheumatoid Arthritis Patients.
    Am J Surg Pathol. 2018 May 5. doi: 10.1097/PAS.0000000000001071.
    PubMed     Text format     Abstract available


    Blood

  2. HU S, Wang Y
    Diffuse large B-cell lymphoma with strong aberrant expression of CD31.
    Blood. 2018;131:2090.
    PubMed     Text format    

  3. MANSON G, Herbaux C, Brice P, Bouabdallah K, et al
    Prolonged remissions after anti-PD1 discontinuation in patients with Hodgkin lymphoma.
    Blood. 2018 May 3. pii: blood-2018-03-841262. doi: 10.1182/blood-2018-03-841262.
    PubMed     Text format    


    BMC Cancer

  4. ZHANG H, Rose BJ, Pyuen AA, Thamm DH, et al
    In vitro antineoplastic effects of auranofin in canine lymphoma cells.
    BMC Cancer. 2018;18:522.
    PubMed     Text format     Abstract available

  5. ROGASCH JMM, Hundsdoerfer P, Hofheinz F, Wedel F, et al
    Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphoma.
    BMC Cancer. 2018;18:521.
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  6. DREGER P, Michallet M, Bosman P, Dietrich S, et al
    Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0207.
    PubMed     Text format     Abstract available


    Br J Haematol

  7. ZHU KY, Song KW, Connors JM, Leitch H, et al
    Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
    Br J Haematol. 2018 May 9. doi: 10.1111/bjh.15262.
    PubMed     Text format     Abstract available

  8. VERA-LOZADA G, Barros MHM, Alves P, Segges P, et al
    EOMES/TBET and soluble CTLA4/full length CTLA4 expression ratios impact on the therapeutic response in patients with classical Hodgkin lymphoma.
    Br J Haematol. 2018 May 9. doi: 10.1111/bjh.15253.
    PubMed     Text format    

  9. ROMAGUERA JE, Lee HJ, Tarapore R, Prabhu V, et al
    Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment.
    Br J Haematol. 2018 May 8. doi: 10.1111/bjh.15271.
    PubMed     Text format    


    Cancer

  10. KELLER FG, Castellino SM, Chen L, Pei Q, et al
    Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.
    Cancer. 2018 May 8. doi: 10.1002/cncr.31519.
    PubMed     Text format     Abstract available


    Cancer Res

  11. HU T, Chong Y, Lu S, Wang R, et al
    MicroRNA 339 promotes development of Stem Cell Leukemia/Lymphoma syndrome via downregulation of the BCL2L11 and BAX pro-apoptotic genes.
    Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-4049.
    PubMed     Text format     Abstract available

  12. VERMI W, Micheletti A, Finotti G, Tecchio C, et al
    slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP.
    Cancer Res. 2018 May 10. pii: 0008-5472.CAN-17-2344.
    PubMed     Text format     Abstract available

  13. WANG SS, Carrington M, Berndt SI, Slager SL, et al
    HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.
    Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-2900.
    PubMed     Text format     Abstract available


    Eur J Haematol

  14. BJORKHOLM M, Weibull CE, Eloranta S, Smedby KE, et al
    Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma - a population-based study from Sweden.
    Eur J Haematol. 2018 May 4. doi: 10.1111/ejh.13090.
    PubMed     Text format     Abstract available


    Haematologica

  15. STORTI S, Spina M, Pesce EA, Salvi F, et al
    Rituximab plus Bendamustine as front line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin's lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.
    Haematologica. 2018 May 10. pii: haematol.2017.186569.
    PubMed     Text format     Abstract available

  16. TRNENY M, Verhoef G, Dyer MJ, Yehuda DB, et al
    A Phase 2 multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.
    Haematologica. 2018 May 10. pii: haematol.2017.168401.
    PubMed     Text format     Abstract available

  17. MELANI C, Advani R, Roschewski M, Walters KM, et al
    End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted-EPOCH-R: A paradigm shift in clinical decision making.
    Haematologica. 2018 May 10. pii: haematol.2018.192492.
    PubMed     Text format     Abstract available


    Int J Cancer

  18. GAO R, Liang JH, Wang L, Zhu HY, et al
    Low Serum Cholesterol Levels Predict Inferior Prognosis and Improve NCCN-IPI Scoring in Diffuse Large B Cell Lymphoma.
    Int J Cancer. 2018 May 9. doi: 10.1002/ijc.31590.
    PubMed     Text format     Abstract available


    J Virol

  19. QIAO J, Cao Y, Zabaleta J, Yang L, et al
    Regulation of virus-associated lymphoma growth and gene expression by bacterial quorum sensing molecules.
    J Virol. 2018 May 9. pii: JVI.00478-18. doi: 10.1128/JVI.00478.
    PubMed     Text format     Abstract available


    Lancet Oncol

  20. DI LORENZO S, Corradino B, Panzarella V
    Non-Hodgkin B-cell lymphoma involving the palate.
    Lancet Oncol. 2018;19:e275.
    PubMed     Text format    


    Leuk Lymphoma

  21. SETHI TK, Reddy NM
    Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies.
    Leuk Lymphoma. 2018 May 9:1-13. doi: 10.1080/10428194.2018.1466296.
    PubMed     Text format     Abstract available


    Leukemia

  22. SUN W, Malvar J, Sposto R, Verma A, et al
    Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study.
    Leukemia. 2018 Mar 15. pii: 10.1038/s41375-018-0094.
    PubMed     Text format     Abstract available


    N Engl J Med

  23. BORCHARD NA, Nayak JV
    Orbital Apex Syndrome.
    N Engl J Med. 2018;378:e23.
    PubMed     Text format    


    Radiother Oncol

  24. DENG XW, Wu JX, Wu T, Zhu SY, et al
    Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
    Radiother Oncol. 2018 May 5. pii: S0167-8140(18)30217.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: